Cell therapy based on mesenchymal stromal cells and their derivatives in the comprehensive treatment of chronic periodontitis
Kazan medical journal · 27.05.2026 · 107 (3) · 418-428
DOI: 10.17816/kmj701829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kazan medical journal, online erschienen am 27.05.2026. Verfasst von Zhanna V. Dzampaeva und 5 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Chronic periodontitis is a widespread infectious inflammatory disease that leads to the destruction of the connective tissue and bony structures of the periodontium and is a primary cause of tooth loss in the adult population. Analysis of published data confirms the increasing incidence of periodontitis worldwide, regardless of age and sex, necessitating the development of not only early diagnostic methods but also effective treatment and preventive approaches. Conventional treatments aimed at controlling infection and inflammation cannot achieve complete regeneration of destroyed tissues. Consequently, a promising area of research involves investigating the potential of cell therapy using mesenchymal stromal cells. This review summarizes current data on the role of mesenchymal stromal cells from various origins (dental pulp, periodontal ligament, bone marrow, gingiva) in the pathogenesis and treatment of periodontitis. It examines both direct mechanisms (differentiation into osteoblasts and cementoblasts) and paracrine effects, including pronounced immunomodulation (restoration of the Th17/Treg cell balance, macrophage polarization), effects on angiogenesis, as well as the secretion of extracellular vesicles and exosomes. The results of preclinical studies on the efficacy of both mesenchymal stromal cells and their secretome in in vivo and in vitro models were analyzed. Particular attention was paid to the molecular mechanisms regulating the osteogenic differentiation of these cells under inflammatory conditions, including the role of long noncoding RNAs, microRNAs, and key signaling pathways in the pathogenesis of chronic periodontitis. The review also addresses the impact of systemic factors such as diabetes mellitus and aging on the regenerative potential of mesenchymal stromal cells. Based on a systematic analysis of the available data, it can be concluded that these cells and their derivatives possess high therapeutic potential for periodontal regeneration, opening new horizons for their application in clinical practice.
Zitieren
APA
Dzampaeva, Z. V., Dzlieva, A. K., Khubaeva, A. A., Gergaulova, M. M., Dzaraeva, L. B., & Tagaeva, S. R. (2026). Cell therapy based on mesenchymal stromal cells and their derivatives in the comprehensive treatment of chronic periodontitis. Kazan medical journal, 107(3), 418-428. https://doi.org/10.17816/kmj701829
Vancouver
Dzampaeva ZV, Dzlieva AK, Khubaeva AA, Gergaulova MM, Dzaraeva LB, Tagaeva SR. Cell therapy based on mesenchymal stromal cells and their derivatives in the comprehensive treatment of chronic periodontitis. Kazan medical journal. 2026;107(3):418-428. doi:10.17816/kmj701829
BibTeX
@article{Dzampaeva2026,
author = {Dzampaeva, Zhanna V. and Dzlieva, Agunda K. and Khubaeva, Anna A. and Gergaulova, Maria M. and Dzaraeva, Ludmila B. and Tagaeva, Svetlana R.},
title = {Cell therapy based on mesenchymal stromal cells and their derivatives in the comprehensive treatment of chronic periodontitis},
journal = {Kazan medical journal},
year = {2026},
volume = {107},
number = {3},
pages = {418--428},
doi = {10.17816/kmj701829}
}
EUVIMED